Submerged-culture mycelia and broth of the maitake medicinal mushroom Grifola frondosa (higher basidiomycetes) alleviate type 2 diabetes-induced alterations in immunocytic function

International Journal of Medicinal Mushrooms

Volumn 17, Issue 6, 2015, Pages 541-556

  Chen, Ya Hui ^a   Lee, Chien Hsing ^b   Hsu, Tai Hao ^c   Lo, Hui Chen ^d  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY CHILDREN S HOSPITAL   (Taiwan)

^c DA YEH UNIVERSITY   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Cytokines; Diabetes; Grifola frondosa; Immunocytes; Medicinal mushrooms; Submerged culture

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 6; NICOTINAMIDE; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL PRODUCT; CULTURE MEDIUM; CYTOKINE; GLUCOSE BLOOD LEVEL; IMMUNOLOGIC FACTOR; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GLUCOSE BLOOD LEVEL; GRIFOLA FRONDOSA; HYPERGLYCEMIA; IMMUNOMODULATION; INNATE IMMUNITY; INSULIN BLOOD LEVEL; LYMPHOCYTE FUNCTION; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; SPLEEN CELL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; SUBMERGED CELL CULTURE; ANALYSIS; ANIMAL; CHEMISTRY; CULTURE MEDIUM; DIABETES MELLITUS, TYPE 2; DIET; DRUG EFFECTS; GRIFOLA; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; MACROPHAGE; METABOLISM; MYCELIUM; ORAL DRUG ADMINISTRATION; PROCEDURES; SECRETION (PROCESS); T LYMPHOCYTE; TREATMENT OUTCOME; WISTAR RAT;

BASIDIOMYCOTA; GRIFOLA FRONDOSA; RATTUS; RATTUS NORVEGICUS;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL PRODUCTS; BLOOD GLUCOSE; CULTURE MEDIA; CYTOKINES; DIABETES MELLITUS, TYPE 2; DIET; GRIFOLA; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; MACROPHAGES; MALE; MYCELIUM; PLACEBOS; RATS, WISTAR; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 84934766679     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushrooms.v17.i6.50     Document Type: Article

References (35)

1. International Diabetes Federation. IDF Diabetes Atlas, 6th ed. Brussels, Belgium: International Diabetes Federation. 2013 [cited 2015 June 14]. Available from: http:// www.idf.org/diabetesatlas
2. World Health Organization [cited 2015 June 14]. Available from: http://www.who.int/mediacentre/factsheets/ fs312/en/
3. Wasser SP. Akavia E. Regulatory issues of mushrooms as functional foods and dietary supplements: safety and efficacy. In: Cheung PCK, editor. Mushrooms as functional foods. Hoboken, NJ: Wiley; 2008. p. 199-221.
4. Kristiansen OP, Mandrup-Poulsen T. Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes. 2005;54 Suppl 2:S114-24.
5. Alexandraki KI, Piperi C, Ziakas PD, Apostolopoulos NV, Makrilakis K, Syriou V, Diamanti-Kandarakis E, Kaltsas G, Kalofoutis A. Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation. J Clin Immunol. 2008;28:314-21.
6. Afzal N, Zaman S, Asghar A, Javed K, Shahzad F, Zafar A, Nagi AH. Negative association of serum IL-6 and IL -17 with type-II diabetes retinopathy. Iran J Immunol. 2014;11:40-48.
7. Alexandraki K, Piperi C, Kalofoutis C, Singh J, Alaveras A, Kalofoutis A. Inflammatory process in type 2 diabetes: The role of cytokines. Ann N Y Acad Sci. 2006;1084:89-117.
8. Black PH. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Med Hypotheses. 2006;67:879-91.
9. Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J, Dorfman R, Wang Y, Zielenski J, Mastronardi F, Maezawa Y, Drucker DJ, Engleman E, Winer D, Dosch HM. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med. 2009;15:921-29.
10. Lo HC, Hsu TH, Chen CY. Submerged culture mycelium and broth of Grifola frondosa improve glycemic responses in diabetic rats. Am J Chin Med. 2008;36:265-85.
11. Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, Tsui H, Wu P, Davidson MG, Alonso MN, Leong HX, Glassford A, Caimol M, Kenkel JA, Tedder TF, McLaughlin T, Miklos DB, Dosch HM, Engleman EG. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med. 2011;17:610-17.
12. Ma X, Zhou F, Chen Y, Zhang Y, Hou L, Cao X, Wang C. A polysaccharide from Grifola frondosa relieves insulin resistance of HepG2 cell by Akt-GSK-3 pathway. Glycoconj J. 2014;31:355-63.
13. Lo HC, Wasser SP. H.-Ch. Medicinal mushrooms for glycemic control in diabetes mellitus: history, current status, future perspectives, and unsolved problems (review). Int J Med Mushrooms.2011;13(5):401-26.
14. Cui FJ, Tao WY, Xu ZH, Guo WJ, Xu HY, Ao ZH, Jin J, Wei YQ. Structural analysis of anti-tumor heteropolysaccharide GFPS1b from the cultured mycelia of Grifola frondosa GF9801. Bioresour Technol. 2007;98:395-401.
15. Phan CW, David P, Naidu M, Wong KH, Sabaratnam V. Therapeutic potential of culinary-medicinal mushrooms for the management of neurodegenerative diseases: diversity, metabolite, and mechanism. Crit Rev Biotechnol. 2014. [Epub ahead of print]
16. Fukushima M, Ohashi T, Fujiwara Y, Sonoyama K, Nakano M. Cholesterol-lowering effects of maitake (Grifola frondosa) fiber, shiitake (Lentinus edodes) fiber, and enokitake (Flammulina velutipes) fiber in rats. Exp Biol Med (Maywood). 2001;226:758-65.
17. Masuda Y, Inoue H, Ohta H, Miyake A, Konishi M, Nanba H. Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice. Int J Cancer. 2013;133:108-19.
18. Tian J, Ma J, Ma K, Guo H, Baidoo SE, Zhang Y, Yan J, Lu L, Xu H, Wang S. β-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells. Eur J Immunol. 2013;43:1220-30.
19. Fang J, Wang Y, Lv X, Shen X, Ni X, Ding K. Structure of a β-glucan from Grifola frondosa and its antitumor effect by activating Dectin-1/Syk/NF-κB signaling. Glycoconj J. 2012;29:365-77.
20. Kodama N, Murata Y, Nanba H. Administration of a polysaccharide from Grifola frondosa stimulates immune function of normal mice. J Med Food. 2004;7:141-45.
21. Kodama N, Mizuno S, Nanba H, Saito N. Potential antitumor activity of a low-molecular-weight protein fraction from Grifola frondosa through enhancement of cytokine production. J Med Food. 2010;13:20-30.
22. Tsao YW, Kuan YC, Wang JL, Sheu F. Characterization of a novel maitake (Grifola frondosa) protein that activates natural killer and dendritic cells and enhances antitumor immunity in mice. J Agric Food Chem. 2013;61:9828-38.
23. Bi Y, Miao Y, Han Y, Xu J, Wang Q. Biological and physicochemical properties of two polysaccharides from the mycelia of Grifola umbellate. Carbohydr Polym. 2013;95:740-45.
24. Zhou C, Qiao Y, Tang Q, Jia W, Liu Y, Wu A. Purification and characterization of a novel small-molecule polysaccharide from the Maitake medicinal mushroom Grifola frondosa (higher Basidiomycetes). Int J Med Mushrooms. 2013;15:145-52.
25. Yeh JY, Hsieh LH, Wu KT, Tsai CF. Antioxidant properties and antioxidant compounds of various extracts from the edible basidiomycete Grifola frondosa (Maitake). Molecules. 2011;16:3197-211.
26. Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, Novelli M, Ribes G. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes. 1998;47:224-29.
27. Morris DL, Komocsar WJ. Immunophenotyping analysis of peripheral blood, splenic, and thymic lymphocytes in male and female rats. J Pharmacol Toxicol Methods. 1997;37:37-46.
28. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diab Care. 2004;27:813-23.
29. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factoralpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem. 2003;278:45777-84.
30. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102-10.
31. Menart-Houtermans B, Rütter R, Nowotny B, Rosenbauer J, Koliaki C, Kahl S, Simon MC, Szendroedi J, Schloot NC, Roden M; German Diabetes Study Group. Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: results from the German Diabetes Study (GDS). Diab Care. 2014;37:2326-33.
32. Mayell M. Maitake extracts and their therapeutic potential. Altern Med Rev. 2001;6(1):48-60.
33. Wu MJ, Cheng TL, Cheng SY, Lian TW, Wang L, Chiou SY. Immunomodulatory properties of Grifola frondosa in submerged culture. J Agric Food Chem. 2006;54:2906- 14.
34. Lin JT, Liu WH. o-Orsellinaldehyde from the submerged culture of the edible mushroom Grifola frondosa exhibits selective cytotoxic effect against Hep 3B cells through apoptosis. J Agric Food Chem. 2006;54:7564-9.
35. Wang L, Ha CL, Cheng TL, Cheng SY, Lian TW, Wu MJ. Oral administration of submerged cultivated Grifola frondosa enhances phagocytic activity in normal mice. J Pharm Pharmacol. 2008;60:237-43.